AARON COHEN

Issues related to taxation of insurance companies and their products, and regulation of insurance companies and insurance products. Education and advocacy around taxation of fraternal benefit societies, S.Con.Res.10 and H.Con.Res.65. Taxation of life insurance and advocacy around 501(c)(8) fraternal benefit societies.

Issues related to taxation of insurance companies and their products, and regulation of insurance companies and insurance products. Education and advocacy around taxation of fraternal benefit societies, S.Con.Res.10 and H.Con.Res.65. Taxation of life insurance and advocacy around 501(c)(8) fraternal benefit societies.

Issues related to taxation of insurance companies and their products, and regulation of insurance companies and insurance products. Education and advocacy around taxation of fraternal benefit societies, S.Con.Res.10 and H.Con.Res.65. Taxation of life insurance and advocacy around 501(c)(8) fraternal benefit societies.

Medicare Coverage and Reimbursement issues, including issues related to the Medicare Part B and D Coverage; Issues related to drug pricing; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 5376, Build Back Better Act (Public Law No: 117-169).

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-owned hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act of 2021, and S. 4130, the Patient Access to Higher Quality Care Act of 2022; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-owned hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-owned hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act of 2021, and S. 4130, the Patient Access to Higher Quality Care Act of 2022; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-led hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Legislative and regulatory matters related to physician reimbursement for and patient access to radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography; and CMS implementation of a clinical labor update to the Medicare physician fee schedule practice expense calculation. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Medicare quality standards for hospitals and transplant programs. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2. Enhance Center for Medicare & Medicaid Innovation quality initiatives.

Medicare quality standards for hospitals and transplant programs. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2. Enhance Center for Medicare & Medicaid Innovation quality initiatives.

Legislative and regulatory matters related to reimbursement for radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Monitor implementation of healthcare quality, cost, and access and related health care reform efforts. Coronavirus response efforts, including support for health care providers and patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Issues related to Medicare Part D and prescription drug pricing and patient access, including related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. 117-169), including provisions in Title 1, Subtitle B - Prescription Drug Pricing Reform: Part 1, Lowering Prices Through Drug Price Negotiation; Part 2, Prescription Drug Inflation Rebates; and Part 3, Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Monitor implementation of healthcare quality, cost, and access and related health care reform efforts. Coronavirus response efforts, including support for health care providers and patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Monitor implementation of healthcare quality, cost, and access and related health care reform efforts. Coronavirus response efforts, including support for health care providers and patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, P.L. 117-57, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Monitor implementation of healthcare quality, cost, and access and related health care reform efforts. Coronavirus response efforts, including support for health care providers and patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Legislative and regulatory matters related to reimbursement for radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Medicare Coverage and Reimbursement issues, including issues related to the Medicare Part B and D Coverage; Issues related to drug pricing; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 5376, Build Back Better Act.

340B Program issues and patient access to pharmaceuticals, including monitor related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in Division F, FDA User Fee Reauthorization Act, of H.R. 6833, providing continuing appropriations for FY 2023. Incentives for antimicrobial and antiviral research and novel product development, including related provisions in H.R. 3932, to establish a program to develop antimicrobial innovations.

Medicare Coverage and Reimbursement issues, including issues related to the Medicare Part B and D Coverage; Issues related to drug pricing; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 5376, Build Back Better Act (Public Law No: 117-169); H.R. 2617 - Consolidated Appropriations Act, 2023 (P.L. No: 117-328), issues related to Medicare Part D emergency use authorization coverage; H.R. 3932 (PASTEUR Act).

Issues related to Medicare Part D and prescription drug pricing and patient access, including related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. 117-169), including provisions in Title 1, Subtitle B - Prescription Drug Pricing Reform: Part 1, Lowering Prices Through Drug Price Negotiation; Part 2, Prescription Drug Inflation Rebates; and Part 3, Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act of 2021, and S. 4130, the Patient Access to Higher Quality Care Act of 2022; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-led hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in H.R. 7667, Food and Drug Amendments Act and S. 4348, Food and Drug Administration Safety and Landmark Advancements Act; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 4040, the Advancing Telehealth Beyond COVID-19 Act of 2022, H.R. 1677/S. 620, the KEEP Telehealth Options Act and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and H.R. 5376, Inflation Reduction Act of 2022 (Public Law No: 117-169), including provisions regarding application of Maximum Fair Prices and conforming amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/ H.R. 3173, and H.R. 8487, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Legislative and regulatory matters related to physician reimbursement for and patient access to radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography; and CMS implementation of a clinical labor update to the Medicare physician fee schedule practice expense calculation. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-owned hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-owned hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-owned hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Monitor implementation of the 340B Prescription Drug Discount Program; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 5376, Build Back Better Act.

Medicare Coverage and Reimbursement issues, including issues related to the Medicare Part B and D Coverage; Issues related to drug pricing; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 5376, Build Back Better Act.

Legislative and regulatory matters related to physician reimbursement for and patient access to radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography; and CMS implementation of a clinical labor update to the Medicare physician fee schedule practice expense calculation. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

340B Program issues and patient access to pharmaceuticals, including monitor related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in Division F, FDA User Fee Reauthorization Act, of H.R. 6833, providing continuing appropriations for FY 2023. Incentives for antimicrobial and antiviral research and novel product development, including related provisions in H.R. 3932, to establish a program to develop antimicrobial innovations.

Medicare quality standards for hospitals and transplant programs. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives.

Medicare quality standards for hospitals and transplant programs. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2. Enhance Center for Medicare & Medicaid Innovation quality initiatives.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-owned hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-owned hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-owned hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act of 2021, and S. 4130, the Patient Access to Higher Quality Care Act of 2022; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-led hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act of 2021, and S. 4130, the Patient Access to Higher Quality Care Act of 2022; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-led hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-owned hospitals, including related provisions in H.R. 1330, the Patient Access to Higher Quality Care Act of 2021, and S. 4130, the Patient Access to Higher Quality Care Act of 2022; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-owned hospitals. Coronavirus response efforts, including support for health care providers, patients and small business, and enable physician-owned hospitals to respond to COVID-19, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Legislative issues related to S.477 and H.R. 1366, the Hospitality and Commerce Job Recovery Act of 2021; monitor related legislative efforts supporting the convention, trade show and travel industries; monitor legislative and regulatory impacts of the Tax Cuts and Jobs Act (P.L. 115-97).

Legislative issues related to S.477 and H.R. 1366, the Hospitality and Commerce Job Recovery Act of 2021; monitor related legislative efforts supporting the convention, trade show and travel industries; monitor legislative and regulatory impacts of the Tax Cuts and Jobs Act (P.L. 115-97).

Legislative issues related to S.477 and H.R. 1366, the Hospitality and Commerce Job Recovery Act of 2021; monitor related legislative efforts supporting the convention, trade show and travel industries; monitor legislative and regulatory impacts of the Tax Cuts and Jobs Act (P.L. 115-97).

Legislative issues related to S.477 and H.R. 1366, the Hospitality and Commerce Job Recovery Act of 2021; monitor related legislative efforts supporting the convention, trade show and travel industries; monitor legislative and regulatory impacts of the Tax Cuts and Jobs Act (P.L. 115-97).

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Coronavirus response efforts, including support for health care providers, patients, and related provisions in S. 3799, the PREVENT Pandemics Act and H.R.1667, Dr. Lorna Breen Health Care Provider Protection Act (Public Law No: 117-105), and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 4040, the Advancing Telehealth Beyond COVID-19 Act of 2022, H.R. 1677/S. 620, the KEEP Telehealth Options Act and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and H.R. 5376, Inflation Reduction Act of 2022 (Public Law No: 117-169), including provisions regarding application of Maximum Fair Prices and conforming amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/ H.R. 3173, and H.R. 8487, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Legislative and regulatory matters related to physician reimbursement for and patient access to radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography; and CMS implementation of a clinical labor update to the Medicare physician fee schedule practice expense calculation. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Legislative and regulatory matters related to reimbursement for radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Legislative and regulatory matters related to physician reimbursement for and patient access to radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography; and CMS implementation of a clinical labor update to the Medicare physician fee schedule practice expense calculation. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Legislative and regulatory matters related to reimbursement for radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Legislative and regulatory matters related to physician reimbursement for and patient access to radiation oncology treatment; including implementation of related provisions in H.R. 2029, Consolidated Appropriations Act, regarding incentives for digital radiography; and CMS implementation of a clinical labor update to the Medicare physician fee schedule practice expense calculation. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 4040, the Advancing Telehealth Beyond COVID-19 Act of 2022, H.R. 1677/S. 620, the KEEP Telehealth Options Act and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and H.R. 5376, Inflation Reduction Act of 2022 (Public Law No: 117-169), including provisions regarding application of Maximum Fair Prices and conforming amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/ H.R. 3173, and H.R. 8487, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

340B Program issues and patient access to pharmaceuticals, including monitor related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in Division F, FDA User Fee Reauthorization Act, of H.R. 6833, providing continuing appropriations for FY 2023. Incentives for antimicrobial and antiviral research and novel product development, including related provisions in H.R. 3932, to establish a program to develop antimicrobial innovations.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in H.R. 7667, Food and Drug Amendments Act and S. 4348, Food and Drug Administration Safety and Landmark Advancements Act; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 5376 the Build Back Better Act, including provisions regarding Lowering Prices Through Drug Price Negotiation, establishment of a Drug Price Negotiation Program, and Medicare Inflation Rebates, including related provisions in Sections 139001, 139002, 139101, and 139102, and related provisions in the Senate Finance Committee posted amendment to H.R. 5376; and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, P.L. 117-57, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in the Consolidated Appropriations Act, 2023, PL 117-328, in Sec. 4111, extending Medicare advanced alternative payment model incentive payments, Sec. 4112 extending Medicare physician payment support, and Division O PAYGO waiver for FY 2023 and 2024. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in the Consolidated Appropriations Act, 2023, PL 117-328, in Sec. 4113, extending telehealth flexibilities beyond the COVID-19 PHE. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

340B Program issues and patient access to pharmaceuticals, including monitor related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in Division F, FDA User Fee Reauthorization Act, of H.R. 6833, providing continuing appropriations for FY 2023. Incentives for antimicrobial and antiviral research and novel product development, including related provisions in H.R. 3932, to establish a program to develop antimicrobial innovations.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in the Consolidated Appropriations Act, 2023, PL 117-328, in Sec. 4111, extending Medicare advanced alternative payment model incentive payments, Sec. 4112 extending Medicare physician payment support, and Division O PAYGO waiver for FY 2023 and 2024. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in the Consolidated Appropriations Act, 2023, PL 117-328, in Sec. 4113, extending telehealth flexibilities beyond the COVID-19 PHE. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and including related provisions in H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2021, Division P, Title III, Subtitle A Telehealth Flexibility Extension; and H.R. 1677/S. 620, the KEEP Telehealth Options Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

340B Program issues and patient access to pharmaceuticals, including monitor related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in Division F, FDA User Fee Reauthorization Act, of H.R. 6833, providing continuing appropriations for FY 2023. Incentives for antimicrobial and antiviral research and novel product development, including related provisions in H.R. 3932, to establish a program to develop antimicrobial innovations.

340B Program issues and patient access to pharmaceuticals, including related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in H.R. 7667, Food and Drug Amendments Act and S. 4348, Food and Drug Administration Safety and Landmark Advancements Act; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2) and H.R. 5376, the Build Back Better Act, Section 31022, Funding for Public Health and Preparedness Research, Development and Countermeasure Capacity, regarding the SNS, supply chains and domestic manufacturing.

340B Program issues and patient access to pharmaceuticals, including monitor related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in Division F, FDA User Fee Reauthorization Act, of H.R. 6833, providing continuing appropriations for FY 2023. Incentives for antimicrobial and antiviral research and novel product development, including related provisions in H.R. 3932, to establish a program to develop antimicrobial innovations.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act, including: maintain patient access to In-Office Ancillary Services; implementation of Electronic Health Records meaningful use requirements; CMS implementation of misvalued codes; and Medicare sequestration. Medicare beneficiary access to telehealth, including related provisions in H.R. 2471, the Consolidated Appropriations Act, 2022, P.L. 117-103, Division P, Title III, Subtitle A Telehealth Flexibility Extension; H.R. 1677/S. 620, the KEEP Telehealth Options Act, and Discussion Draft of bipartisan Senate Finance Committee legislation, the Telemental Health Access to Care Act. Medicare Part B reimbursement for prescription drugs and related issues to enhance patient access to covered drugs and CMMI quality initiatives, including: use of step therapy in Medicare and health insurance coverage, including related provisions in S. 464/H.R. 2163, the Safe Step Act; and in H.R. 5376, the Build Back Better Act - including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Confirming Amendments to modify Medicare Part B reimbursement for selected drugs; and physician reimbursement issues related to CMMI Most Favored Nation demonstration. Medicare beneficiary access to drugs/advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 3018/H.R. 3173, the Improving Seniors Timely Access to Care Act, and H.R. 7995, the GOLD CARD Act, to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans. Coronavirus response and support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Monitor Medicare vision coverage provisions in H.R. 5376, the Build Back Better Act.

Medicare Coverage and Reimbursement issues, including issues related to the Medicare Part B and D Coverage; Issues related to drug pricing; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 5376, Build Back Better Act (Public Law No: 117-169); H.R. 2617 - Consolidated Appropriations Act, 2023 (P.L. No: 117-328), issues related to Medicare Part D emergency use authorization coverage; H.R. 3932 (PASTEUR Act).

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in H.R. 3173, the Improving Seniors Timely Access to Care Act. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in S. 464 and HR 2163, the Safe Step Act. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2; and S. 748, the Medicare Sequester Relief Act and HR 315, the Medicare Sequester COVID Moratorium Act; and S. 610/HR 1667, the Lorna Breen Health Care Provider Protection Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor the CMMI most favored nation demonstration.